Cambridge Cognition Secures £2.5 Million Funding biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.
Cambridge Cognition spin-out Monument Therapeutics accesses £1.5m for schizophrenia clinical development Cambridge Cognition Holdings plc (AIM: COG), which develops and markets digital solutions to assess brain health, is pleased to announce that Monument Therapeutics Limited (“Monument”) a p.
Cambridge Cognition Holdings PLC on Tuesday said that a precision neuroscience company that it spun-out from and partly owns has accessed GBP1.5 million in funding for clinical development of a.